ADIAL PHARMACEUTICALS, INC. — Form D

ADIAL PHARMACEUTICALS, INC. of GLEN ALLEN, VA, a company, filed a Form D exempt-offering notice with the SEC on 2017-05-16. The offering totals $288K, of which $288K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
James Kermit AndersonDirectorCharlottesville, VA
Leonard D MeyerDirectorCharlottesville, VA
James W Newman, Jr.DirectorGlen Allen, VA
James K AndersonDirectorGlen Allen, VA
Vinay J ShahExecutive OfficerGlen Allen, VA
Robertson H GillilandDirectorGlen Allen, VA
Tony W GoodmanDirectorGlen Allen, VA
Tony W GoodmanExecutive OfficerGlen Allen, VA
Kevin W Schuyler, CFADirectorGlen Allen, VA
Cary J ClaiborneDirectorGlen Allen, VA
Cary J ClaiborneExecutive OfficerGlen Allen, VA
Joseph M TruluckExecutive OfficerGlen Allen, VA
William B Stilley, IIIDirectorCharlottesville, VA
William B Stilley, IIIExecutive OfficerCharlottesville, VA
Cary W ClaiborneDirectorCharlottesville, VA
Cary W ClaiborneExecutive OfficerCharlottesville, VA
Kevin W SchuylerDirectorCharlottesville, VA
Jack W ReichDirectorCharlottesville, VA
WIlliam StilleyExecutive Officercharlottesville, VA
Wendy L YarnoDirectorCharlottesville, VA
William B StilleyDirectorCharlottesville, VA
William B StilleyExecutive OfficerCharlottesville, VA
Mike L KingDirectorCharlottesville, VA
Bankole A JohnsonDirectorCharlottesville, VA
Bankole A JohnsonExecutive OfficerCharlottesville, VA

Other filings by this issuer (18)

Showing 15 of 18 filings.

FiledFormOfferingSold
2025-12-03D$4.3M$4.3M
2025-05-14D$4.8M$4.8M
2024-03-14D$288K$288K
2023-10-26D$4.0M$4.0M
2023-06-05D$3.1M$53K
2023-03-06D$62K$62K
2022-02-17D$10.0M$10.0M
2021-07-12D$5.0M$500K
2021-03-26D$2.1M$291K
2020-11-30D$15.3M$296K
2020-09-25D$500K$500K
2020-06-17D$5.2M$5.2M
2018-06-14D$325K$325K
2018-03-13D$500K$500K
2017-12-05D$100K$100K

More